×
About 810 results

ALLMedicine™ Activated Clotting Time Center

Research & Reviews  399 results

Comprehensive Intraprocedural Unfractionated Heparin Protocol During Catheter Ablation ...
https://doi.org/10.1177/1074248421998492
Journal of Cardiovascular Pharmacology and Therapeutics; Safani M, Tobias S et. al.

Mar 22nd, 2021 - Data on optimal dosing of unfractionated heparin (UFH) in the presence of a direct oral anticoagulant (DOAC) to achieve and maintain an activated clotting time (ACT) of ≥300 seconds during catheter ablation of atrial fibrillation (CA-AF) are limit...

Routine fixed-dose heparin vs. ACT-guided heparin administration for elective PCI and i...
https://doi.org/10.1097/MCA.0000000000001008
Coronary Artery Disease; Berkowitz O, Halabi M et. al.

Mar 4th, 2021 - Activated clotting time (ACT)-based heparin dosing during percutaneous intervention (PCI) is recommended by Society guidelines. However, the relationship between ACT and outcome in the setting of elective PCI has not been sufficiently studied. We ...

Variability of Activated Clotting Time by Site of Sample Draw During Percutaneous Coron...
https://doi.org/10.1177/0003319721992237
Angiology Morris JH, Lee JA et. al.

Feb 4th, 2021 - The activated clotting time (ACT) assay is used to monitor and titrate anticoagulation therapy with unfractionated heparin during percutaneous coronary intervention (PCI). Observations at our institution suggested a considerable difference between...

Protocol driven periprocedural anticoagulation for left atrial ablation.
https://doi.org/10.1111/jce.14892
Journal of Cardiovascular Electrophysiology; Bradley CJ, Williamson BD et. al.

Jan 21st, 2021 - A weight-based heparin dosing policy adjusted for preprocedural oral anticoagulation was implemented to reduce the likelihood of subtherapeutic dosing during left atrial catheter ablation procedures. We hypothesized that initiation of the protocol...

Activated Clotting Time (ACT) for Monitoring of Low-Dose Heparin: Performance Character...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758671
Clinical and Applied Thrombosis/hemostasis : Official Jou... Wehner JE, Boehne M et. al.

Dec 22nd, 2020 - Dose adjustment of unfractionated heparin (UFH) anticoagulation is an important factor to reduce hemorrhagic events. High doses of heparin can be monitored by Activated Clotting Time (ACT). Because of limited information about the monitoring of lo...

see more →

Clinicaltrials.gov  407 results

Comprehensive Intraprocedural Unfractionated Heparin Protocol During Catheter Ablation ...
https://doi.org/10.1177/1074248421998492
Journal of Cardiovascular Pharmacology and Therapeutics; Safani M, Tobias S et. al.

Mar 22nd, 2021 - Data on optimal dosing of unfractionated heparin (UFH) in the presence of a direct oral anticoagulant (DOAC) to achieve and maintain an activated clotting time (ACT) of ≥300 seconds during catheter ablation of atrial fibrillation (CA-AF) are limit...

Routine fixed-dose heparin vs. ACT-guided heparin administration for elective PCI and i...
https://doi.org/10.1097/MCA.0000000000001008
Coronary Artery Disease; Berkowitz O, Halabi M et. al.

Mar 4th, 2021 - Activated clotting time (ACT)-based heparin dosing during percutaneous intervention (PCI) is recommended by Society guidelines. However, the relationship between ACT and outcome in the setting of elective PCI has not been sufficiently studied. We ...

Variability of Activated Clotting Time by Site of Sample Draw During Percutaneous Coron...
https://doi.org/10.1177/0003319721992237
Angiology Morris JH, Lee JA et. al.

Feb 4th, 2021 - The activated clotting time (ACT) assay is used to monitor and titrate anticoagulation therapy with unfractionated heparin during percutaneous coronary intervention (PCI). Observations at our institution suggested a considerable difference between...

Protocol driven periprocedural anticoagulation for left atrial ablation.
https://doi.org/10.1111/jce.14892
Journal of Cardiovascular Electrophysiology; Bradley CJ, Williamson BD et. al.

Jan 21st, 2021 - A weight-based heparin dosing policy adjusted for preprocedural oral anticoagulation was implemented to reduce the likelihood of subtherapeutic dosing during left atrial catheter ablation procedures. We hypothesized that initiation of the protocol...

Activated Clotting Time (ACT) for Monitoring of Low-Dose Heparin: Performance Character...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758671
Clinical and Applied Thrombosis/hemostasis : Official Jou... Wehner JE, Boehne M et. al.

Dec 22nd, 2020 - Dose adjustment of unfractionated heparin (UFH) anticoagulation is an important factor to reduce hemorrhagic events. High doses of heparin can be monitored by Activated Clotting Time (ACT). Because of limited information about the monitoring of lo...

see more →

News  4 results

Heparin Dosing Oddities in the Cath Lab: A 'Red Flag' Raises Questions
https://www.staging.medscape.com/viewarticle/918035

Sep 9th, 2019 - The peculiar heparin behavior started about 6 months ago. Dosing that had been reliable countless times in the cath lab was failing to get the activated clotting time (ACT) to target, forcing extra boluses. "I called my pharmacy and asked them to ...

Heparin Dosing Oddities in the Cath Lab: A 'Red Flag' Raises Questions
https://www.medscape.com/viewarticle/918035

Sep 9th, 2019 - The peculiar heparin behavior started about 6 months ago. Dosing that had been reliable countless times in the cath lab was failing to get the activated clotting time (ACT) to target, forcing extra boluses. "I called my pharmacy and asked them to ...

Relationship Between Activated Clotting Time During Percutaneous Intervention and Subsequent Bleeding Complications
https://www.medscape.com/viewarticle/441652

Abstract and Introduction Background: Approximately 50% of percutaneous coronary interventions in the United States are performed with unfractionated heparin and no IIb/IIIa agent. The operator must weigh the risks and benefits of more intensive a...

Relationship Between Activated Clotting Time During Percutaneous Intervention and Subsequent Bleeding Complications
https://www.medscape.com/viewarticle/441652_1

Abstract and Introduction Background: Approximately 50% of percutaneous coronary interventions in the United States are performed with unfractionated heparin and no IIb/IIIa agent. The operator must weigh the risks and benefits of more intensive a...

see more →